Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup

Affiliation

• ¹ *Department of Gynecology and Obstetrics, IRCCS San Raffaele Hospital, Milan, Italy; †Gynecologic Oncology Department, Catholic University of the Sacred Heart, Rome/Campobasso, Italy; ‡Gynecologic Oncology Group, The University of Texas MD Anderson Cancer Center, Houston, TX; §AGO Study Group, Gynecologic Oncology Center, Kiel, Germany; ∥Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; ¶ANZGOG, Camperdown, New South Wales, Australia; #Department of Obstetrics and Gynecology, University of Hong Kong, Queen Mary Hospital, Hong Kong, People's Republic of China; **Centre de Référence des Maladie Trophoblastiques, Hospices Civils de Lyon, Lyon, France; ††Department of Obstetrics and Gynecology, Institute of Maternal and Child Health, Medical College, Calicut, India; ‡‡GTD unit, University Hospital of Caracas, Central University of Venezuela, Caracas, Venezuela; §§The Spanish Ovarian Cancer Research Group (GEICO), Fundación Instituto Valenciano de Oncología, Valencia, Spain; ∥∥Korean Gynaecologic Oncology Group, Seoul National University Hospital, Seoul, South Korea; ¶¶Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; ##Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and ***Charing Cross Trophoblastic Disease Centre, Departments of Histopathology and Medical Oncology, Charing Cross Campus of Imperial College London, London, United Kingdom.